We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
- Authors
Hoon, Dave SB; Spugnardi, Mia; Kuo, Christine; Huang, Sharon K; Morton, Donald L; Taback, Bret
- Abstract
Aberrant methylation of CpG islands in promoter regions of tumor suppressor genes (TSG) has been demonstrated in epithelial origin tumors. However, the methylation profiling of tumor-related gene promoter regions in cutaneous melanoma tumors has not been reported. Seven known or candidate TSGs that are frequently hypermethylated in carcinomas were assessed by methylation-specific polymerase chain reaction (MSP) in 15 melanoma cell lines and 130 cutaneous melanoma tumors. Four TSGs were frequently hypermethylated in 86 metastatic tumor specimens: retinoic acid receptor-ß2 (RAR-ß2) (70%), RAS association domain family protein 1A (RASSF1A) (57%), and O6-methylguanine DNA methylatransferase (MGMT) (34%), and death-associated protein kinase (DAPK) (19%). Hypermethylation of MGMT, RASSF1A, and DAPK was significantly lower in primary melanomas (n=20) compared to metastatic melanomas. However, hypermethylation of RAR-ß2 was 70% in both primary and metastatic melanomas. Cell lines had hypermethylation profiles similar to those of metastatic melanomas. The analysis of these four markers of metastatic tumors demonstrated that 97% had ⩾1 gene(s) and 59% had ⩾2 genes hypermethylated. The methylation of genes was verified by bisulfite sequencing. The mRNA transcripts could be re-expressed in melanoma cell lines having hypermethylated genes following treatment with 5'-aza 2'-deoxycytidine (5Aza-dC). Analysis of melanoma patients’ plasma (preoperative blood; n=31) demonstrated circulating hypermethylated MGMT, RAR-ß2, and RASSF1A DNA for at least one of the markers in 29% of the patients. Our findings indicate that the incidence of TSG hypermethylation increases during tumor progression. Methylation of TSG may play a significant role in cutaneous melanoma progression.
- Subjects
MELANOMA; TUMOR suppressor genes; METHYLATION; PROMOTERS (Genetics); CANCER patients; CANCER genetics
- Publication
Oncogene, 2004, Vol 23, Issue 22, p4014
- ISSN
0950-9232
- Publication type
Article
- DOI
10.1038/sj.onc.1207505